Related references
Note: Only part of the references are listed.Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent
Ghenwa Nasreddine et al.
INVESTIGATIONAL NEW DRUGS (2020)
Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion
Houssam Al-Koussa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Global trends in colorectal cancer mortality: projections to the year 2035
Marzieh Araghi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth
Shiro L. Cramer et al.
NATURE MEDICINE (2017)
Doxironide Magnetic Nanoparticles for Selective Drug Delivery to Human Acute Myeloid Leukemia
Kheireddine El-Boubbou et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2017)
Antitumor activity of β-2-himachalen-6-ol in colon cancer is mediated through its inhibition of the PI3K and MAPK pathways
Hamid E. Daaboul et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion
Saleh Al-Dimasi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas
Gregory R. Bean et al.
CELL DEATH & DISEASE (2016)
The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma
Chen Lin et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)
Daucus carota Pentane-Based Fractions Suppress Proliferation and Induce Apoptosis in Human Colon Adenocarcinoma HT-29 Cells by Inhibiting the MAPK and PI3K Pathways
Wassim N. Shebaby et al.
JOURNAL OF MEDICINAL FOOD (2015)
Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells
Oula Khoury et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)
Amira Bekdash et al.
TRANSLATIONAL ONCOLOGY (2015)
Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells
Juan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Effect of StarD13 on colorectal cancer proliferation, motility and invasion
Anita Nasrallah et al.
ONCOLOGY REPORTS (2014)
Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy
Chun A. Changou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
Francis Mussai et al.
BLOOD (2013)
Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells
Rita Tanios et al.
LEUKEMIA RESEARCH (2013)
Cytotoxicity of Anthrax Lethal Toxin to Human Acute Myeloid Leukemia Cells Is Nonapoptotic and Dependent on Extracellular Signal-Regulated Kinase 1/2 Activity
Elias Kassab et al.
TRANSLATIONAL ONCOLOGY (2013)
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
N. Syed et al.
CELL DEATH & DISEASE (2013)
Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells
Vaidehi Agrawal et al.
ANTI-CANCER DRUGS (2012)
Inhibition of autophagy impairs tumor cell invasion in an organotypic model
Robin L. Macintosh et al.
CELL CYCLE (2012)
Recombinant Human Arginase Toxicity in Mice Is Reduced by Citrulline Supplementation
Jeremy P. Mauldin et al.
TRANSLATIONAL ONCOLOGY (2012)
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis
B. Delage et al.
CELL DEATH & DISEASE (2012)
The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma
Suzanne M. Cloonan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Bioengineered Human Arginase I with Enhanced Activity and Stability Controls Hepatocellular and Pancreatic Carcinoma Xenografts
Evan S. Glazer et al.
TRANSLATIONAL ONCOLOGY (2011)
Replacing Mn2+ with Co2+ in Human Arginase I Enhances Cytotoxicity toward L-Arginine Auxotrophic Cancer Cell Lines
Everett M. Stone et al.
ACS CHEMICAL BIOLOGY (2010)
FTY720 induces necrotic cell death and autophagy in ovarian cancer cells A protective role of autophagy
Ning Zhang et al.
AUTOPHAGY (2010)
Pegylated arginase I: a potential therapeutic approach in T-ALL
Claudia P. Hernandez et al.
BLOOD (2010)
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Barbara Delage et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Autophagy: cellular and molecular mechanisms
Danielle Glick et al.
JOURNAL OF PATHOLOGY (2010)
Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes
Macus Tien Kuo et al.
ONCOTARGET (2010)
Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
T. L. Lam et al.
CANCER LETTERS (2009)
Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis
Randie H. Kim et al.
CANCER RESEARCH (2009)
Autophagy: molecular machinery, regulation, and implications for renal pathophysiology
Sudharsan Periyasamy-Thandavan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511
Meir Wetzler et al.
BLOOD (2007)
Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase
Cheol-Yong Yoon et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion
Paul Ning-Man Cheng et al.
CANCER RESEARCH (2007)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Share Paper
